These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1039 related articles for article (PubMed ID: 9264286)

  • 21. Diversity of envelope glycoprotein from human immunodeficiency virus type 1 of recent seroconverters in Thailand.
    McCutchan FE; Viputtigul K; de Souza MS; Carr JK; Markowitz LE; Buapunth P; McNeil JG; Robb ML; Nitayaphan S; Birx DL; Brown AE
    AIDS Res Hum Retroviruses; 2000 May; 16(8):801-5. PubMed ID: 10826486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic and antigenic variability of HIV type 1 in Brazil.
    Couto-Fernandez JC; Janssens W; Heyndrickx L; Motte J; Fransen K; Peeters M; Delaporte E; Galvão-Castro B; Piot P; van der Groen G
    AIDS Res Hum Retroviruses; 1994 Sep; 10(9):1157-63. PubMed ID: 7545972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An HIV type 1 subtype B founder effect in Korea: gp160 signature patterns infer circulation of CTL-escape strains at the population level.
    Daniels RS; Kang C; Patel D; Xiang Z; Douglas NW; Zheng NN; Cho HW; Lee JS
    AIDS Res Hum Retroviruses; 2003 Aug; 19(8):631-41. PubMed ID: 13678464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic analysis of HIV-1 isolates from Brazil reveals presence of two distinct genetic subtypes.
    Louwagie J; Delwart EL; Mullins JI; McCutchan FE; Eddy G; Burke DS
    AIDS Res Hum Retroviruses; 1994 May; 10(5):561-7. PubMed ID: 7917518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic diversity of human immunodeficiency virus type 1 strains in Kinshasa, Zaire.
    Potts KE; Kalish ML; Bandea CI; Orloff GM; St Louis M; Brown C; Malanda N; Kavuka M; Schochetman G; Ou CY
    AIDS Res Hum Retroviruses; 1993 Jul; 9(7):613-8. PubMed ID: 8369166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simultaneous introduction of distinct HIV-1 subtypes into different risk groups in Russia, Byelorussia and Lithuania.
    Lukashov VV; Cornelissen MT; Goudsmit J; Papuashvilli MN; Rytik PG; Khaitov RM; Karamov EV; de Wolf F
    AIDS; 1995 May; 9(5):435-9. PubMed ID: 7639968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of antibody reactivity to human immunodeficiency virus type 1 (HIV-1) gp160 epitopes in sera from HIV-1-infected individuals from Tanzania and from the United States.
    Warren RQ; Nkya WM; Shao JF; Anderson SA; Wolf H; Hendrix CW; Kanda P; Wabuke M; Boswell RN; Redfield RR
    J Clin Microbiol; 1992 Jan; 30(1):126-31. PubMed ID: 1370844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improbability of harmful autoimmune responses resulting from immunization with HIV-1 envelope glycoproteins.
    Neurath AR; Strick N; Li YY; Jiang S
    AIDS Res Hum Retroviruses; 1993 Dec; 9(12):1195-208. PubMed ID: 8142138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relative reactivity of the V3 loop PND of HIV-1 subtypes A, B, C, D, and F with sera from selected Ugandan localities.
    Riley JP; Pestano GA; Hosford K; Francis C; Xie JM; Mugyenyi P; Kataaha P; Katongole-Mbidde E; Anokbonggo WW; Guyden J
    Arch Virol; 1995; 140(8):1393-404. PubMed ID: 7544970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distribution of linear antigenic epitopes on GP120 encoded in sibling clones of novel New York HIV-1 subtype B isolates.
    Riley JP; Pestano GA; Harewood K; Alfred LJ; Guyden J; Boto WM
    Cell Mol Biol (Noisy-le-grand); 1995; 41 Suppl 1():S83-91. PubMed ID: 8574151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selected amino acid changes in HIV-1 subtype-C gp41 are associated with specific gp120(V3) signatures in the regulation of co-receptor usage.
    Dimonte S; Babakir-Mina M; Mercurio F; Di Pinto D; Ceccherini-Silberstein F; Svicher V; Perno CF
    Virus Res; 2012 Sep; 168(1-2):73-83. PubMed ID: 22732432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV type 1 in Thailand, 1994-1995: persistence of two subtypes with low genetic diversity.
    Subbarao S; Limpakarnjanarat K; Mastro TD; Bhumisawasdi J; Warachit P; Jayavasu C; Young NL; Luo CC; Shaffer N; Kalish ML; Schochetman G
    AIDS Res Hum Retroviruses; 1998 Mar; 14(4):319-27. PubMed ID: 9519893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of correlation between V3-loop peptide enzyme immunoassay serologic subtyping and genetic sequencing.
    Nkengasong JN; Willems B; Janssens W; Cheingsong-Popov R; Heyndrickx L; Barin F; Ondoa P; Fransen K; Goudsmit J; van der Groen G
    AIDS; 1998 Aug; 12(12):1405-12. PubMed ID: 9727560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serologic and phylogenetic characterization of HIV-1 subtypes in Uganda.
    Brennan CA; Lund JK; Golden A; Yamaguchi J; Vallari AS; Phillips JF; Kataaha PK; Jackson JB; Devare SG
    AIDS; 1997 Dec; 11(15):1823-32. PubMed ID: 9412700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High prevalence of antibodies to the gp120 V3 region principal neutralizing determinant of HIV-1MN in sera from Africa and the Americas.
    Carrow EW; Vujcic LK; Glass WL; Seamon KB; Rastogi SC; Hendry RM; Boulos R; Nzila N; Quinnan GV
    AIDS Res Hum Retroviruses; 1991 Oct; 7(10):831-8. PubMed ID: 1720630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation and structural analysis of soluble oligomeric gp140 envelope proteins derived from neutralization-resistant and neutralization-susceptible primary HIV type 1 isolates.
    Stamatatos L; Lim M; Cheng-Mayer C
    AIDS Res Hum Retroviruses; 2000 Jul; 16(10):981-94. PubMed ID: 10890360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthetic peptide strategy for the detection of and discrimination among highly divergent primate lentiviruses.
    Simon F; Souquière S; Damond F; Kfutwah A; Makuwa M; Leroy E; Rouquet P; Berthier JL; Rigoulet J; Lecu A; Telfer PT; Pandrea I; Plantier JC; Barré-Sinoussi F; Roques P; Müller-Trutwin MC; Apetrei C
    AIDS Res Hum Retroviruses; 2001 Jul; 17(10):937-52. PubMed ID: 11461679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic variability of HIV type 1 in Kenya.
    Janssens W; Heyndrickx L; Fransen K; Temmerman M; Leonaers A; Ivens T; Motte J; Piot P; Van der Groen G
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1577-9. PubMed ID: 7888213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seroreactivity of analogous antigenic epitopes in glycoprotein 120 expressed in HIV-1 subtypes A, B, C, and D.
    Pestano GA; Hosford KS; Spira AI; Riley J; Xie JM; Sewankambo N; Brown L; Ho DD; Boto WM
    AIDS Res Hum Retroviruses; 1995 May; 11(5):589-96. PubMed ID: 7576915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutations in both gp120 and gp41 are responsible for the broad neutralization resistance of variant human immunodeficiency virus type 1 MN to antibodies directed at V3 and non-V3 epitopes.
    Park EJ; Vujcic LK; Anand R; Theodore TS; Quinnan GV
    J Virol; 1998 Sep; 72(9):7099-107. PubMed ID: 9696803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 52.